- Kura Oncology (KURA, Financial) to take part within the Financial institution of America Securities 2025 Healthcare Convention.
- CEO Troy Wilson will have interaction in a hearth chat on Might 13, 2025, at 6:00 p.m. ET / 3:00 p.m. PT.
- Dwell and archived webcast of the presentation shall be accessible on Kura’s web site.
Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical firm centered on precision medicines for most cancers remedy, has introduced its participation within the upcoming Financial institution of America Securities 2025 Healthcare Convention. The corporate’s President and CEO, Troy Wilson, Ph.D., J.D., is scheduled to take part in a hearth chat on Might 13, 2025, at 6:00 p.m. ET / 3:00 p.m. PT. Traders and events can entry the stay audio webcast by the Traders part of Kura’s web site at www.kuraoncology.com, with a replay accessible following the occasion.
Kura Oncology is dedicated to growing focused therapies aimed toward treating numerous kinds of most cancers. The corporate’s pipeline consists of small molecule drug candidates comparable to ziftomenib, an investigational remedy that has acquired Breakthrough Remedy Designation from the FDA for the remedy of relapsed/refractory NPM1-mutant acute myeloid leukemia (AML). In collaboration with Kyowa Kirin Co., Ltd., Kura Oncology is advancing its growth and commercialization efforts on this space. Moreover, Kura is conducting trials to guage the efficacy of its drug candidates together with present requirements of take care of a number of most cancers sorts.
